Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion type Assertion NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_head.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion description "[Activating mutations in NOTCH1 are present in over 50% of human T-cell lymphoblastic leukemia (T-ALL) samples and inhibition of NOTCH1 signaling with gamma-secretase inhibitors (GSI) has emerged as a potential therapeutic strategy for the treatment of this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion evidence source_evidence_literature NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion SIO_000772 16688224 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion wasDerivedFrom befree-20140225 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion wasGeneratedBy ECO_0000203 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.